Lars Munksgaard

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Second primary cancers in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia-cumulative burden without generalized excess cancer risk.

Second primary cancers in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia-cumulative burden without generalized excess cancer risk.

Journal: British journal of haematology
Published: June 01, 2026

Time to Next Treatment Within 24 Months (TTNT24) as a Predictor of Survival in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia: A Population-Based Observational Study.

Time to Next Treatment Within 24 Months (TTNT24) as a Predictor of Survival in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia: A Population-Based Observational Study.

Journal: European journal of haematology
Published: June 30, 2025

Biomarker-adapted treatment in high-risk large B-cell lymphoma.

Biomarker-adapted treatment in high-risk large B-cell lymphoma.

Journal: HemaSphere
Published: November 29, 2024

Central nervous system involvement in Waldenström macroglobulinemia: a comparative population-based study of Bing-Neel syndrome and histological transformation.

Central nervous system involvement in Waldenström macroglobulinemia: a comparative population-based study of Bing-Neel syndrome and histological transformation.

Journal: Annals of hematology
Published: November 12, 2024

Extramedullary disease in Waldenström macroglobulinemia: A population-based observational study.

Extramedullary disease in Waldenström macroglobulinemia: A population-based observational study.

Journal: EJHaem
Published: August 25, 2024

Prognostic impact of nodal involvement in Waldenström macroglobulinaemia.

Prognostic impact of nodal involvement in Waldenström macroglobulinaemia.

Journal: British journal of haematology
Published: August 03, 2024

Mutational landscape in Waldenström macroglobulinemia evaluated using a next-generation sequencing lymphoma panel in routine clinical practice.

Mutational landscape in Waldenström macroglobulinemia evaluated using a next-generation sequencing lymphoma panel in routine clinical practice.

Journal: Leukemia & lymphoma
Published: February 10, 2024

Bone Involvement as a Primary Rare Manifestation of Waldenstrom Macroglobulinemia: A Case Report and Prevalence in a Nationwide Population-Based Cohort Study.

Bone Involvement as a Primary Rare Manifestation of Waldenstrom Macroglobulinemia: A Case Report and Prevalence in a Nationwide Population-Based Cohort Study.

Journal: Journal of hematology
Published: October 31, 2022

Cardiovascular diseases in elderly survivors of diffuse large B-cell lymphoma: a Danish population-based cohort study.

Cardiovascular diseases in elderly survivors of diffuse large B-cell lymphoma: a Danish population-based cohort study.

Journal: Leukemia & lymphoma
Published: April 19, 2022

Core needle biopsy is an inferior tool for diagnosing cervical lymphoma compared to lymph node excision.

Core needle biopsy is an inferior tool for diagnosing cervical lymphoma compared to lymph node excision.

Journal: Acta oncologica (Stockholm, Sweden)
Published: May 18, 2021

Introduction of a Comprehensive Diagnostic and Interdisciplinary Management Approach in Haematological Patients with Mucormycosis: A Pre and Post-Intervention Analysis.

Introduction of a Comprehensive Diagnostic and Interdisciplinary Management Approach in Haematological Patients with Mucormycosis: A Pre and Post-Intervention Analysis.

Journal: Journal of fungi (Basel, Switzerland)
Published: September 09, 2020

Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis.

Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis.

Journal: Blood advances
Published: January 17, 2020
Showing 1-12 of 18

Last Updated: 09/26/2026